The Oncology Nursing Society has released the findings of a recent survey of oncology nurses that show they are increasingly concerned about invasive fungal infections in their patients.
ONSEdge, a healthcare education company and the for-profit subsidiary of the Oncology Nursing Society, released the findings of a recent survey of oncology nurses that show they are increasingly concerned about invasive fungal infections (IFIs) in their patients. Oncology nurses clearly recognize the importance of IFIs to patients who undergo stem cell transplantation and/or high-dose chemotherapy.
-- Oncology nurses understand the risk of IFIs in certain oncology categories: Seventy percent of respondents indicated that patients with myelodysplastic syndromes (MDS) who were neutropenic were at high to very high risk for IFIs. Additionally, 79 percent indicated that patients with acute myelogenous leukemia who were neutropenic were at high to very high risk. Finally, 66 percent believed that patients who were stem cell transplant recipients and who developed graft-versus-host-disease (GVHD) were at high to very high risk.
-- Oncology nurses understand the importance of prophylaxis: Seventy-seven percent agreed with the statement, "I am convinced that antifungal prophylaxis is the best approach to managing the risk of developing invasive fungal infection."
-- Oncology nurses are increasingly concerned about IFIs: Sixty-eight percent agreed with the statement, "I am increasingly concerned about invasive fungal infections as a complication in my high-risk patients."
An ONSEdge white paper titled, "Knowledge Report: Invasive Fungal Infections," which reviews the survey findings and provides additional information, confirms that oncology nurses concerns about a rise of IFIs in patients with cancer are well founded. The report details the likely cause of the increase, patients who are at most risk, and what can be done to prevent IFIs.
The sharp rise over the past two decades is due in large part to the immunosuppression experienced by increased number of patients undergoing hematopoietic stem cell transplant (HSCT). Because such patients are highly susceptible to bacterial and viral infections, oncology nurses are concerned about the significant number of opportunistic infections due to fungi, especially Aspergillus.
The report indicates that patient populations most at risk as identified by evidence-based guidelines include:
-- Individuals with profound, prolonged neutropenia (low white cell counts)
-- Individuals with acute leukemia, myelodysplastic syndromes
-- Allogeneic hematopoietic stem cell transplantation (HSCT) recipients
-- Individuals with graft-versus-host-disease (GVHD a frequent complication of HSCT)
-- Autologous HSCT recipients with mucositis
The white paper includes recommendations on how oncology nurses and other healthcare providers can play a major role in preventing and/or minimizing IFIs in their immunosuppressed patients. They must be prepared by:
-- Understanding how to identify high-risk patients
-- Recognizing the sources of IFIs and the vectors by which they are transmitted
-- Maintaining a high level of suspicion that any symptoms experienced by patients could be caused by IFIs
-- Knowing and applying the established clinical practice guidelines for prevention and treatment
The survey was funded by Merck & Co., Inc., Whitehouse Station, N.J.
For the full report, visit www.onsedge.com/pdf/IFIKnowledgeReport.pdf.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.